Adaptive Biotechnologies (ADPT) Amortization of Deferred Charges (2022 - 2025)
Adaptive Biotechnologies (ADPT) posted Amortization of Deferred Charges of -$1.7 million for Q3 2025, down 43300.0% sequentially from $4000.0 in Q2 2025, and down 380.06% YoY from $617000.0 in Q3 2024.
Adaptive Biotechnologies (ADPT) Amortization of Deferred Charges (2022 - 2025) Analysis & Trends
Adaptive Biotechnologies has reported Amortization of Deferred Charges for 4 years, with the latest figure at -$1.7 million in Q3 2025.
- Quarterly Amortization of Deferred Charges fell 380.06% year-over-year to -$1.7 million in Q3 2025, while the trailing twelve-month figure through Sep 2025 was -$862000.0 (down 131.05% YoY) and the FY2024 annual result came in at $2.6 million, down 50.6% from the prior year.
- Amortization of Deferred Charges eased to -$1.7 million in Q3 2025 per ADPT's latest filing, from $4000.0 in the prior quarter.
- Over five years, Amortization of Deferred Charges peaked at $1.8 million in Q3 2023 and troughed at -$1.7 million in Q3 2025.
- A 4-year average of $567416.7 and a median of $598000.0 in 2024 frame the typical range for Amortization of Deferred Charges.
- The sharpest annual moves came in 2023 and 2025: Amortization of Deferred Charges surged 121.99% in 2023, then sank 380.06% in 2025.
- Over 4 years, Amortization of Deferred Charges stood at $332000.0 in 2022, then soared by 121.99% to $737000.0 in 2023, then decreased by 21.44% to $579000.0 in 2024, then sank by 398.45% to -$1.7 million in 2025.
- According to Business Quant data, Amortization of Deferred Charges over the past three periods registered -$1.7 million, $4000.0, and $283000.0 for Q3 2025, Q2 2025, and Q1 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.40 Bn | 209.33 Bn | 8.34 Bn |
| 2 | Danaher | 139.94 Bn | 135.59 Bn | 3.61 Bn |
| 3 | Idexx Laboratories | 46.03 Bn | 45.83 Bn | 779.09 Mn |
| 4 | Agilent Technologies | 39.69 Bn | 37.88 Bn | 990.00 Mn |
| 5 | Iqvia Holdings | 39.32 Bn | 37.24 Bn | 1.44 Bn |
| 6 | Natera | 38.47 Bn | 37.37 Bn | 696.04 Mn |
| 7 | Illumina | 29.98 Bn | 28.82 Bn | 770.00 Mn |
| 8 | Mettler Toledo International | 28.57 Bn | 28.52 Bn | 650.22 Mn |
| 9 | Quest Diagnostics | 26.21 Bn | 25.58 Bn | 1.03 Bn |
| 10 | Adaptive Biotechnologies | 3.80 Bn | 3.58 Bn | 52.17 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -1.73 Mn |
| Sep 30, 2025 | -1.73 Mn |
| Jun 30, 2025 | 4,000.00 |
| Jun 30, 2025 | 4,000.00 |
| Mar 31, 2025 | 283,000.00 |
| Mar 31, 2025 | 283,000.00 |
| Dec 31, 2024 | 579,000.00 |
| Dec 31, 2024 | 579,000.00 |
| Sep 30, 2024 | 617,000.00 |
| Sep 30, 2024 | 617,000.00 |
| Jun 30, 2024 | 537,000.00 |
| Jun 30, 2024 | 537,000.00 |
| Mar 31, 2024 | 885,000.00 |
| Mar 31, 2024 | 885,000.00 |
| Dec 31, 2023 | 737,000.00 |
| Dec 31, 2023 | 737,000.00 |
| Sep 30, 2023 | 1.76 Mn |
| Sep 30, 2023 | 1.76 Mn |
| Jun 30, 2023 | 1.16 Mn |
| Jun 30, 2023 | 1.16 Mn |